* We recommend a score >= 0.08 for meaningful Gene-Disease associations

GeneID	Gene_Symbol	DisGeNet_diseaseID	Disease_name	DisGeNet score	DisGeNet_sourceDB
4773	NFATC2	C0027765	nervous system disorder	0.2	CTD_human
4773	NFATC2	C0009319	Colitis	0.00328236603323995	BEFREE;LHGDN
4773	NFATC2	C1458155	Mammary Neoplasms	0.00328236603323995	BEFREE;LHGDN
4773	NFATC2	C0002874	Aplastic Anemia	0.00300763924902685	BEFREE;LHGDN
4773	NFATC2	C0006413	Burkitt Lymphoma	0.00300763924902685	BEFREE;LHGDN
4773	NFATC2	C0027404	Narcolepsy	0.0029564820917142	BEFREE;GAD
4773	NFATC2	C0023418	leukemia	0.00273291246481375	LHGDN
4773	NFATC2	C0024299	Lymphoma	0.00273291246481375	LHGDN
4773	NFATC2	C0011570	Mental Depression	0.002407028523288	GAD
4773	NFATC2	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.002407028523288	GAD
4773	NFATC2	C0040336	Tobacco Use Disorder	0.002407028523288	GAD
4773	NFATC2	C0027627	Neoplasm Metastasis	0.0010989071368524	BEFREE
4773	NFATC2	C0235974	Pancreatic carcinoma	0.0010989071368524	BEFREE
4773	NFATC2	C0346647	Malignant neoplasm of pancreas	0.0010989071368524	BEFREE
4773	NFATC2	C0678222	Breast Carcinoma	0.0010989071368524	BEFREE
4773	NFATC2	C0002395	Alzheimer's Disease	0.0008241803526393	BEFREE
4773	NFATC2	C0006142	Malignant neoplasm of breast	0.0008241803526393	BEFREE
4773	NFATC2	C0553580	Ewings sarcoma	0.0008241803526393	BEFREE
4773	NFATC2	C0017636	Glioblastoma	0.0005494535684262	BEFREE
4773	NFATC2	C0017638	Glioma	0.0005494535684262	BEFREE
4773	NFATC2	C0025202	melanoma	0.0005494535684262	BEFREE
4773	NFATC2	C0280100	solid tumor	0.0005494535684262	BEFREE
4773	NFATC2	C0699790	Colon Carcinoma	0.0005494535684262	BEFREE
4773	NFATC2	C2239176	Liver carcinoma	0.0005494535684262	BEFREE
4773	NFATC2	C0002726	Amyloidosis	0.0002747267842131	BEFREE
4773	NFATC2	C0003873	Rheumatoid Arthritis	0.0002747267842131	BEFREE
4773	NFATC2	C0004364	Autoimmune Diseases	0.0002747267842131	BEFREE
4773	NFATC2	C0007102	Malignant tumor of colon	0.0002747267842131	BEFREE
4773	NFATC2	C0008479	Chondrosarcoma	0.0002747267842131	BEFREE
4773	NFATC2	C0009324	Ulcerative Colitis	0.0002747267842131	BEFREE
4773	NFATC2	C0009375	Colonic Neoplasms	0.0002747267842131	BEFREE
4773	NFATC2	C0009402	Colorectal Carcinoma	0.0002747267842131	BEFREE
4773	NFATC2	C0009404	Colorectal Neoplasms	0.0002747267842131	BEFREE
4773	NFATC2	C0011847	Diabetes	0.0002747267842131	BEFREE
4773	NFATC2	C0011849	Diabetes Mellitus	0.0002747267842131	BEFREE
4773	NFATC2	C0013080	Down Syndrome	0.0002747267842131	BEFREE
4773	NFATC2	C0014457	Eosinophilia	0.0002747267842131	BEFREE
4773	NFATC2	C0018801	Heart failure	0.0002747267842131	BEFREE
4773	NFATC2	C0018802	Congestive heart failure	0.0002747267842131	BEFREE
4773	NFATC2	C0019829	Hodgkin Disease	0.0002747267842131	BEFREE
4773	NFATC2	C0023449	Acute lymphocytic leukemia	0.0002747267842131	BEFREE
4773	NFATC2	C0024141	Lupus Erythematosus, Systemic	0.0002747267842131	BEFREE
4773	NFATC2	C0026769	Multiple Sclerosis	0.0002747267842131	BEFREE
4773	NFATC2	C0028754	Obesity	0.0002747267842131	BEFREE
4773	NFATC2	C0032285	Pneumonia	0.0002747267842131	BEFREE
4773	NFATC2	C0035309	Retinal Diseases	0.0002747267842131	BEFREE
4773	NFATC2	C0036220	Kaposi Sarcoma	0.0002747267842131	BEFREE
4773	NFATC2	C0040028	Thrombocythemia, Essential	0.0002747267842131	BEFREE
4773	NFATC2	C0042214	Vaccinia	0.0002747267842131	BEFREE
4773	NFATC2	C0043194	Wiskott-Aldrich Syndrome	0.0002747267842131	BEFREE
4773	NFATC2	C0178874	Tumor Progression	0.0002747267842131	BEFREE
4773	NFATC2	C0242379	Malignant neoplasm of lung	0.0002747267842131	BEFREE
4773	NFATC2	C0278883	Metastatic melanoma	0.0002747267842131	BEFREE
4773	NFATC2	C0333516	Tumor necrosis	0.0002747267842131	BEFREE
4773	NFATC2	C0338656	Impaired cognition	0.0002747267842131	BEFREE
4773	NFATC2	C0424295	Hyperactive behavior	0.0002747267842131	BEFREE
4773	NFATC2	C0518964	BRONCHIAL ADENOCARCINOMA	0.0002747267842131	BEFREE
4773	NFATC2	C0520680	Sleep Apnea, Central	0.0002747267842131	BEFREE
4773	NFATC2	C0596263	Carcinogenesis	0.0002747267842131	BEFREE
4773	NFATC2	C0684249	Carcinoma of lung	0.0002747267842131	BEFREE
4773	NFATC2	C0751039	Cockayne Syndrome, Type I	0.0002747267842131	BEFREE
4773	NFATC2	C0856825	Acute GVH disease	0.0002747267842131	BEFREE
4773	NFATC2	C1270972	Mild cognitive disorder	0.0002747267842131	BEFREE
4773	NFATC2	C1301034	Pancreatic intraepithelial neoplasia	0.0002747267842131	BEFREE
4773	NFATC2	C1306460	Primary malignant neoplasm of lung	0.0002747267842131	BEFREE
4773	NFATC2	C1306759	Eosinophilic disorder	0.0002747267842131	BEFREE
4773	NFATC2	C1335302	Pancreatic Ductal Adenocarcinoma	0.0002747267842131	BEFREE
4773	NFATC2	C1621958	Glioblastoma Multiforme	0.0002747267842131	BEFREE
4773	NFATC2	C1704356	Enchondroma	0.0002747267842131	BEFREE
4773	NFATC2	C3203102	Idiopathic pulmonary arterial hypertension	0.0002747267842131	BEFREE
4773	NFATC2	C3494652	Severe dementia	0.0002747267842131	BEFREE
4773	NFATC2	C3714636	Pneumonitis	0.0002747267842131	BEFREE
4773	NFATC2	C3887505	DYSFUNCTION - SKIN DISORDERS	0.0002747267842131	BEFREE